March 20 (Reuters) - Cynata Therapeutics Ltd (CYP) :
- EU REGULATORY & ETHICS APPROVAL FOR PHASE 2 TRIAL OF CYP-001 IN GRAFT VERSUS HOST DISEASE
(([email protected];))
March 20 (Reuters) - Cynata Therapeutics Ltd (CYP) : EU...
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.21M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 23.5¢ | 22.0¢ | $20.38K | 90.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 86380 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 12372 | 2 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
23.0¢ |
Change
0.000 ( 2.22 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.0¢ | 23.0¢ | 10474 | ||
| Last updated 11.40am 09/05/2024 ? | |||||
| CYP (ASX) Chart |